Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis

Area of Science:

• Oncology
• Molecular Biology
• Cancer Genetics

Background:

• Programmed cell death 4 (PDCD4) is a known tumor suppressor gene.
• Its role in lung cancer progression and prognosis requires further elucidation.

Purpose of the Study:

• To investigate the expression levels of PDCD4 in lung tumor cell lines and primary lung carcinomas.
• To determine the correlation between PDCD4 expression and clinicopathological features, including tumor grade, stage, and patient prognosis.

Main Methods:

• Northern blot analysis was used to assess PDCD4 mRNA expression in lung cell lines.
• cDNA microarray analysis compared PDCD4 representation in primary lung tumors versus normal lung tissue.
• Immunohistochemical analysis evaluated PDCD4 protein expression in 124 primary lung carcinomas.

Main Results:

• Reduced PDCD4 mRNA expression was detected in lung cancer cell lines.
• PDCD4 cDNA was significantly underrepresented in primary lung tumors, particularly in high-grade adenocarcinomas.
• PDCD4 protein expression was lost in 83% of primary lung carcinomas and negatively correlated with poor prognosis.
• Loss of PDCD4 expression was associated with higher tumor grade and disease stage, but not tumor size or nodal status.

Conclusions:

• Loss of PDCD4 expression is a frequent event in lung cancer.
• Reduced PDCD4 expression serves as a significant prognostic factor in lung cancer.
• PDCD4 may play a role in the progression of lung tumors, especially adenocarcinomas.